Please join PPMD and Capricor as we host a webinar Wednesday, July 18 at 1pm eastern to discuss the HOPE-2 trial. We will provide a brief background of CAP-1002 and its clinical development to date that has led to this exciting trial. The webinar will also review the trial design, eligibility criteria, and assessments that participants will need to complete if they participate in the trial, as well as the travel policy for participants who need to travel to a trial site.
- Pat Furlong
Founding President & CEO, Parent Project Muscular Dystrophy
- Deborah Ascheim, MD
Chief Medical Officer, Capricor, Inc.
- Craig McDonald, MD
Study Principal Investigator, University of California, Davis
- Linda Marban, PhD
Chief Executive Officer, Capricor, Inc.
Please submit questions in advance to firstname.lastname@example.org (subject line: Capricor Webinar) by Monday, July 16 at 12pm eastern.